Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

66.62 +1.62 (+2.49%)
Delayed Quote Updated: 12:05 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Where CareDx Stands With Analysts ↗
 
Via Benzinga
News headline image
CareDx to Report Second Quarter 2024 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients
From CareDx, Inc.
Via Business Wire
News headline image
Decoding 6 Analyst Evaluations For CareDx ↗
 
Via Benzinga
News headline image
Navigating 5 Analyst Ratings For CareDx ↗
 
Via Benzinga
News headline image
Recap: CareDx Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Outlook For CareDx ↗
 
Via Benzinga
News headline image
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
News headline image
Top 3 Health Care Stocks That May Crash In May ↗
 
Via Benzinga
News headline image
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
From CareDx, Inc.
Via Business Wire
News headline image
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
CDNA Stock Earnings: CareDx Beats EPS, Beats Revenue for Q1 2024 ↗
CDNA stock results show that CareDx beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
CareDx Reports First Quarter 2024 Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
CareDx to Report First Quarter 2024 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
From CareDx, Inc.
Via Business Wire
News headline image
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Appoints Bryan Riggsbee to Its Board of Directors
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
From CareDx, Inc.
Via Business Wire
News headline image
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List ↗
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.